From: Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer
Author, year of publication | No. of patients | Population | Overall 5-year survival | Median survival |
---|---|---|---|---|
Rubin 1996 [23] | 53 | BRCA1/2-OC | ~60 %a | ~80 monthsa |
Pharoah 1999 [7] | 127 | BRCA1/2-OC | 21 % | 20,6 months |
Boyd 2000 [10] | 67 | BRCA1-OC | ~50 %a | ~60 monthsa |
Ramus 2001 [24] | 15 | BRCA1-OC | ~25 %a | 52 months |
Cass 2003 [11] | 33 | BRCA1/2-OC | 65 % | 91 months |
Majdak 2005b [3] | 18 | BRCA1-OC | ~33 %a | ~28 monthsa |
Chetrit 2008 [8] | 213 | BRCA1/2-OC | 46 % | 53,7 months |
Tan 2008 [25] | 22 | BRCA1/2-OC | ~65 %a | 8,4 years |
Kringen 2005 [26] | 30 | BRCA1/2-OC | 33,3 % | - |
Lacour 2011 [27] | 95 | BRCA1/2-OC | ~25 %a | 101,7 months |
Hyman 2012 [9] | 30 | BRCA1-OC | ~60 %a | 6 years |
Vencken 2013 [28] | 245 | BRCA1-OC | 62 % | 6 years |
Bolton 2012 [29] | 909 | BRCA1-OC | 44 % | 4,6 years |
Own material | 66 | BRCA1-OC | 43,9 % | 32,3 months |